Connect Biopharma Holdings Limited (CNTB)
$1.84
$-0.09
(-4.66%)
As on 04-Sep-2026 16:28EDT
Market cap
$116 Mln
Revenue (TTM)
$3 Mln
P/E Ratio
--
P/B Ratio
6.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.4 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0.2
-
Debt to Equity
0
-
Book Value
$0.4
-
EPS
$-1.5
-
Face value
--
-
Shares outstanding
62,974,309
6 Years Aggregate
CFO
$-1,598.97 Mln
EBITDA
$-3,009.62 Mln
Net Profit
$-3,114.28 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
| -34.8 | -6.6 | -17.5 | -7.5 | 32.0 | -40.6 | -- |
|
BSE Sensex
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
| 104.3 | 16.8 | 36.0 | -83.1 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
1.8 | 115.9 | 3.1 | -88.4 | -1,666.4 | -256.8 | -- | 6.5 |
| 86.3 | 12,161.6 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.2 | |
| 72.7 | 10,109.8 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.5 | |
| 59.0 | 14,621.6 | 2,435.9 | 860.6 | 31.0 | 43 | 18.6 | 7.9 | |
| 110.2 | 12,506.3 | 1,663.7 | 413.6 | 36.3 | 430 | 32.3 | 86.7 | |
| 358.2 | 10,603.5 | 440.5 | 241.5 | 33.4 | 18.7 | 44.9 | 8.1 | |
| 117.4 | 9,761.1 | 105.0 | -299.7 | -227.2 | -19.4 | -- | 6.5 | |
| 541.1 | 12,501.2 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 23.9 | |
| 591.3 | 16,503.9 | 2,782.3 | 491.5 | 21.1 | 110.1 | 34.7 | 38.2 | |
| 124.0 | 9,808.7 | 0.0 | -450.1 | -- | -44.6 | -- | 8.4 |
Shareholding Pattern
View DetailsAbout Connect Biopharma Holdings (CNTB)
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute... exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California. Read more
-
Co-Founder, President & Chairman of the Board of Directors
Dr. Wubin Pan M.B.A., Ph.D.
-
Co-Founder, President & Chairman of the Board of Directors
Dr. Wubin Pan M.B.A., Ph.D.
-
Headquarters
San Diego, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Connect Biopharma Holdings (CNTB)
What is the current share price of Connect Biopharma Holdings Limited (CNTB) Today?
The share price of Connect Biopharma Holdings Limited (CNTB) is $1.84 (NASDAQ) as of 04-Sep-2026 16:28 EDT. Connect Biopharma Holdings Limited (CNTB) has given a return of 32% in the last 3 years.
What is the current PB & PE ratio of Connect Biopharma Holdings Limited (CNTB)?
Since, TTM earnings of Connect Biopharma Holdings Limited (CNTB) is negative, P/E ratio is not available.
The P/B ratio of Connect Biopharma Holdings Limited (CNTB) is 6.49 times as on 04-Sep-2026, a 22 premium to its peers’ median range of 5.33 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-2.83 |
3.74 |
2024 |
-4.87 |
0.83 |
2023 |
-1.05 |
0.64 |
2022 |
-0.40 |
0.30 |
2021 |
-1.37 |
1.02 |
What is the 52 Week High and Low of Connect Biopharma Holdings Limited (CNTB)?
The 52-week high and low of Connect Biopharma Holdings Limited (CNTB) are Rs 3.82 and Rs 1.23 as of 07-Sep-2026.
What is the market cap of Connect Biopharma Holdings Limited (CNTB)?
Connect Biopharma Holdings Limited (CNTB) has a market capitalisation of $ 116 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Connect Biopharma Holdings Limited (CNTB)?
Before investing in Connect Biopharma Holdings Limited (CNTB), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.